An Observational Study (Called RETAF-PS) Using a Patient Survey to Learn More About Treatment Outcomes in Patients With Irregular and Often Rapid Heartbeat (Atrial Fibrillation) Treated With Apixaban in a Real World Setting
Clinical trial NCT05471830 · COMPLETED
Trial details
- NCT number
- NCT05471830
- Sponsor
- Bayer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-11-30
- Primary completion
- 2023-12-01
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.